Abstract: A driving assistance apparatus includes: a driving assister that assists driving by a driver of a vehicle, by way of driving assistance functions; and a controller that obtains inattentive state information indicating an inattentive state of the driver, and reduces or deactivates at least one driving assistance function among the driving assistance functions, by controlling the driving assister based on the inattentive state information obtained.

Abstract: A singlet oxygen scavenger includes, as an active component, hexyl diethyl amino hydroxy benzoyl benzoate, 1-(4-methoxy phenyl)-3-(4-tert-butyl phenyl)-1, 3-propanedione, terephthalylidene-3, 3?-dicamphor-10, 10?-disulfonate, 2-ethyl hexyl 4-methoxy cinnamate, or 2-ethyl hexyl 2-cyano-3, 3-diphenyl acrylate; or 2-phenyl benzimidazole-5-sulfonic acid, 4, 4?, 4?-[(1, 3, 5-triazine-2, 4, 6-triyl) tris (imino)] trisbenzoic acid tris (2-ethyl hexyl), octyl salicylate, or 3, 3, 5-trimethyl cyclohexyl salicylate; or 2-hydroxy-4-methoxy-5-(sodiooxysulfonyl) benzophenone, drometrizol trisiloxane, 2-hydroxy-4-methoxy benzophenone, or 4-methyl benzylidene camphor.

Abstract: A driving assistance apparatus includes: a driving assister that assists driving by a driver of a vehicle, by way of driving assistance functions; and a controller that obtains inattentive state information indicating an inattentive state of the driver, and reduces or deactivates at least one driving assistance function among the driving assistance functions, by controlling the driving assister based on the inattentive state information obtained.

Abstract: A singlet oxygen scavenger includes, as an active component, hexyl diethyl amino hydroxy benzoyl benzoate, 1-(4-methoxy phenyl)-3-(4-tert-butyl phenyl)-1, 3-propanedione, terephthalylidene-3,3?-dicamphor-10,10?-disulfonate, 2-ethyl hexyl 4-methoxy cinnamate, or 2-ethyl hexyl 2-cyano-3,3-diphenyl acrylate; or 2-phenyl benzimidazole-5-sulfonic acid, 4,4?,4?-[(1,3,5-triazine-2,4,6-triyl) tris (imino)]trisbenzoic acid tris (2-ethyl hexyl), octyl salicylate, or 3,3,5-trimethyl cyclohexyl salicylate; or 2-hydroxy-4-methoxy-5-(sodiooxysulfonyl) benzophenone, drometrizol trisiloxane, 2-hydroxy-4-methoxy benzophenone, or 4-methyl benzylidene camphor.

Abstract: A command determiner does not send a master command which it has received from a master device through a first interface circuit to a slave device if it determines that the master command does not need to be relayed. In this case, a power controller sets the power mode of a second interface circuit to a low power mode, and a response controller sends, as a slave command, a substitute command corresponding to the master command, which the command determiner has received from the master device through the first interface circuit, to the master device through the first interface circuit.

Abstract: When the electrically driven fan (14) of a vacuum cleaner is driven, air containing dust is drawn into the cleaner main body (1) through a hose (7) connected to a hose socket (8) and is exhausted into the outside of the cleaner main body (1) through an exhaust port (1b) via first and second suction passageways (10, 13). Disposed outside the first suction passageway (10) is an ion generator (23), it being arranged that plus and minus ions generated in the ion generator (23) are fed to the air stream flowing in the first suction passageway (10). Since the plus and minus ions kill floating germs in the air stream, the exhaust can be purified.

Abstract: The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor (GIPF) polynucleotides and polypeptides. The invention further relates to the therapeutic use of GIPF to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.

Abstract: The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor (GIPF) polynucleotides and polypeptides. The invention further relates to the therapeutic use of GIPF to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.

Abstract: When the electrically driven fan (14) of a vacuum cleaner is driven, air containing dust is drawn into the cleaner main body (1) through a hose (7) connected to a hose socket (8) and is exhausted into the outside of the cleaner main body (1) through an exhaust port (1b) via first and second suction passageways (10, 13). Disposed outside the first suction passageway (10) is an ion generator (23), it being arranged that plus and minus ions generated in the ion generator (23) are fed to the air stream flowing in the first suction passageway (10). Since the plus and minus ions kill floating germs in the air stream, the exhaust can be purified.

Abstract: When the electrically driven fan (14) of a vacuum cleaner is driven, air containing dust is drawn into the cleaner main body (1) through a hose (7) connected to a hose socket (8) and is exhausted into the outside of the cleaner main body (1) through an exhaust port (1b) via first and second suction passageways (10, 13). Disposed outside the first suction passageway (10) is an ion generator (23), it being arranged that plus and minus ions generated in the ion generator (23) are fed to the air stream flowing in the first suction passageway (10). Since the plus and minus ions kill floating germs in the air stream, the exhaust can be purified.

Abstract: The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor (GIPF) polynucleotides and polypeptides. The invention further relates to the therapeutic use of GIPF to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.

Abstract: The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor (GIPF) polynucleotides and polypeptides. The invention further relates to the therapeutic use of GIPF to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.

Abstract: The invention relates to pharmaceutical compositions comprising gastrointestinal proliferative factor (GIPF) polynucleotides and polypeptides. The invention further relates to the therapeutic use of GIPF to prevent or treat conditions or disorders associated with the degeneration of the epithelial mucosa.

Abstract: The present invention relates to novel isoxazole and thiazole compounds having an excellent lysophosphatidic acid (LPA) receptor antagonistic activity represented by general formula [1] or salts thereof: wherein R1 and R2 represents an optionally substituted alkyl group or the like; R3 represents a hydrogen atom or the like; R4 represent a group selected from the group consisting of (I) optionally substituted phenyl, aryl, or heterocycle, (II) substituted or nonsubstituted alkyl, and (III) substituted or nonsubstituted alkenyl, alternatively, R3 and R4 may form a ring structure together with a carbon atom to which they bind; and X represents an oxygen atom or a sulfur atom, provided that, when R3 is a hydrogen atom, R4 represents a group other than methyl, and the use thereof as a medicine.

Abstract: When the electrically driven fan (14) of a vacuum cleaner is driven, air containing dust is drawn into the cleaner main body (1) through a hose (7) connected to a hose socket (8) and is exhausted into the outside of the cleaner main body (1) through an exhaust port (1b) via first and second suction passageways (10, 13). Disposed outside the first suction passageway (10) is an ion generator (23), it being arranged that plus and minus ions generated in the ion generator (23) are fed to the air stream flowing in the first suction passageway (10). Since the plus and minus ions kill floating germs in the air stream, the exhaust can be purified.

Abstract: A nozzle unit for an electric vacuum cleaner has a body case with a nozzle open toward a surface to be cleaned, a first pipe coupled to the body case so as to be rotatable in the direction, and a second pipe coupled to the first pipe so as to be rotatable in the direction. A first and a second air flow passage, formed inside the first and second pipes respectively, are arranged substantially in a straight line as seen in a side view. The first pipe has a sliding portion that has an arc-shaped cross section and that slides along the inner surface of the body case, and this sliding portion is arranged inside the body case, which is substantially rectangular, as seen in a plan view.

Abstract: A nozzle unit for an electric vacuum cleaner has a body case 32 with a nozzle 34a open toward a surface to be cleaned, a first pipe 35 coupled to the body case 32 so as to be rotatable in the direction J1, and a second pipe 36 coupled to the first pipe 35 so as to be rotatable in the direction J2. A first and a second air flow passage, formed inside the first and second pipes 35 and 36 respectively, are arranged substantially in a straight line as seen in a side view. The first pipe 35 has a sliding portion 35a that has an arc-shaped cross section and that slides along the inner surface of the body case 32, and this sliding portion 35a is arranged inside the body case 32, which is substantially rectangular, as seen in a plan view.

Abstract: The present invention relates to novel isoxazole and thiazole compounds having an excellent lysophosphatidic acid (LPA) receptor antagonistic activity represented by general formula [1] or salts thereof: 1

Abstract: A nozzle unit for an electric vacuum cleaner has a body case 32 with a nozzle 34a open toward a surface to be cleaned, a first pipe 35 coupled to the body case 32 so as to be rotatable in the direction J1, and a second pipe 36 coupled to the first pipe 35 so as to be rotatable in the direction J2. A first and a second air flow passage, formed inside the first and second pipes 35 and 36 respectively, are arranged substantially in a straight line as seen in a side view. The first pipe 35 has a sliding portion 35a that has an arc-shaped cross section and that slides along the inner surface of the body case 32, and this sliding portion 35a is arranged inside the body case 32, which is substantially rectangular, as seen in a plan view.

Abstract: A nozzle unit for an electric vacuum cleaner has a body case 32 with a nozzle 34a open toward a surface to be cleaned, a first pipe 35 coupled to the body case 32 so as to be rotatable in the direction J1, and a second pipe 36 coupled to the first pipe 35 so as to be rotatable in the direction J2. A first and a second air flow passage, formed inside the first and second pipes 35 and 36 respectively, are arranged substantially in a straight line as seen in a side view. The first pipe 35 has a sliding portion 35a that has an arc-shaped cross section and that slides along the inner surface of the body case 32, and this sliding portion 35a is arranged inside the body case 32, which is substantially rectangular, as seen in a plan view.